CLINICAL_TRIALS trial_result · 2012-10-11

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars [Phase 2]

Phase 2 trial evaluated safety and efficacy of additional doses of AZX100 following excision of keloid scars. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Capstone Therapeutics | Conditions: Scar Prevention, Scar Reduction | Phase 2 | Status: COMPLETED | Results posted: 2012-10-11